A German cohort study relied on continuous long-term monitoring to show the natural history of new-onset Afib after bypass surgery. While the incidence of postoperative Afib was higher than previously ...
Hosted on MSN
AtriCure treats first subject in BoxX-NoAF study
AtriCure has treated the first subject in the randomised Box Lesion Creation with Left Atrial Appendage Exclusion to Reduce the Occurrence of New-onset Atrial Fibrillation (BoxX-NoAF) trial. The study ...
Trial will evaluate the safety and effectiveness of the AtriCure Isolator® Synergy™ EnCompass® clamp and AtriClip® Left Atrial Appendage Exclusion System to reduce the occurrence of new-onset atrial ...
San Francisco-based AliveCor has received FDA clearance for two new algorithms for its smartphone-connected ECG: one that detects normality and one that detects interference. These follow up on ...
New research presented at the EHRA 2025, a scientific congress of the European Society of Cardiology, shows that the presence of atrial fibrillation (AF) increases the risk of future dementia by 21% ...
Smartphone-enabled heart monitor device maker AliveCor has launched a new app for patients, which is both timed with the new iOS 8 launch and incorporates the atrial fibrillation algorithm the company ...
Middle-aged adults with this common type of irregular heart rhythm face greater odds of cognitive impairment, especially the early-onset type, a new study finds. Atrial fibrillation (afib) diagnosed ...
New research presented at the EHRA 2025, a scientific congress of the European Society of Cardiology, shows that the presence of atrial fibrillation (AFib) increases the risk of future dementia by 21% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback